UK markets open in 4 hours 41 minutes

NanJing Pharmaceutical Company Limited (600713.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
4.8500-0.0600 (-1.22%)
As of 10:04AM CST. Market open.
Currency in CNY

Valuation measures4

Market cap (intra-day) 6.43B
Enterprise value 15.25B
Trailing P/E 10.81
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.12
Price/book (mrq)0.97
Enterprise value/revenue 0.29
Enterprise value/EBITDA 11.19

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-19.64%
S&P500 52-week change 324.49%
52-week high 36.3100
52-week low 33.8500
50-day moving average 34.5900
200-day moving average 34.8981

Share statistics

Avg vol (3-month) 39.19M
Avg vol (10-day) 310.45M
Shares outstanding 51.31B
Implied shares outstanding 61.31B
Float 8538.79M
% held by insiders 157.88%
% held by institutions 12.09%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.14
Forward annual dividend yield 42.85%
Trailing annual dividend rate 30.16
Trailing annual dividend yield 33.26%
5-year average dividend yield 42.38
Payout ratio 430.84%
Dividend date 3N/A
Ex-dividend date 418 May 2023
Last split factor 220:10
Last split date 308 Jul 2011

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 1.10%
Operating margin (ttm)3.07%

Management effectiveness

Return on assets (ttm)2.99%
Return on equity (ttm)10.11%

Income statement

Revenue (ttm)53.46B
Revenue per share (ttm)41.29
Quarterly revenue growth (yoy)-0.90%
Gross profit (ttm)N/A
EBITDA 1.69B
Net income avi to common (ttm)587.75M
Diluted EPS (ttm)0.4500
Quarterly earnings growth (yoy)6.70%

Balance sheet

Total cash (mrq)1.64B
Total cash per share (mrq)1.27
Total debt (mrq)10.45B
Total debt/equity (mrq)140.21%
Current ratio (mrq)1.41
Book value per share (mrq)5.10

Cash flow statement

Operating cash flow (ttm)1.47B
Levered free cash flow (ttm)2.2B